What youll learn: Noom and Medvi both connect you with GLP-1 medications online, but the experience around that medication is where they differ
Typical monitoring schedule includes: Baseline assessments: HbA1c, fasting glucose, renal function, liver function, lipid profile, blood pressure, weight, and BMI 3-month review: Assessment of tolerability, weight change, HbA1c (for diabetes), blood pressure, and any adverse effects 6-month review: Comprehensive reassessment including blood tests, weight trajectory, treatment goals achievement, and decision regarding continuation Ongoing reviews: Every 36 months once stable, with annual comprehensive assessments NICE guidance recommends that GLP-1 therapy for diabetes should be continued only if beneficial responses are demonstratedtypically defined as HbA1c reduction of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at 6 months
doi: 10.4103/1995-705X.81548 200
Medication management - from dosage, to refilling prescriptions, to tracking weight loss and mitigating any potential side-effects, with minimum of a monthly telehealth appointment with their clinician